Cathie Wood’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111M Buy
1,610,189
+285,606
+22% +$16.2M 0.72% 40
2026
Q1
$85.1M Buy
1,324,583
+720,022
+119% +$65.7M 0.66% 41
2025
Q4
$78.6M Buy
604,561
+157,582
+35% +$21.6M 0.52% 46
2025
Q3
$48.2M Buy
+446,979
New +$48.7M 0.29% 58
2021
Q4
Sell
-284,712
Closed -$71.3M 370
2021
Q3
$71.3M Buy
284,712
+145,820
+105% +$50.1M 0.17% 90
2021
Q2
$64.2M Buy
138,892
+10,663
+8% +$4.58M 0.12% 110
2021
Q1
$63M Buy
+128,229
New +$66.7M 0.13% 117

Other funds holding WGS

Cathie Wood's WGS Position: Q2 2026 in Review

Cathie Wood increased its GeneDx Holdings (WGS) stake by 22% in Q2 2026, buying an estimated $16.2M and bringing the position to 1,610,189 shares worth $111M. The position accounts for 0.72% of the portfolio, ranked #40.

Cathie Wood first reported a position in WGS in Q1 2021 and has held it in 7 quarters since. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Cathie Wood held 1,610,189 shares of GeneDx Holdings worth $111M as of Q2 2026.
  • Cathie Wood bought 285,606 GeneDx Holdings shares in Q2 2026, an estimated $16.2M.
  • GeneDx Holdings made up 0.72% of Cathie Wood's portfolio in Q2 2026, its #40 holding.
  • Cathie Wood first reported a position in GeneDx Holdings in Q1 2021 and has held it in 7 quarters since.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.